Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The company allocated €56 million to research and development for next-generation line solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity is positioning its technologies as a connected engine for discovery
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Subscribe To Our Newsletter & Stay Updated